IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.

ABSTRACT:

SUBMITTER: Xue SL 

PROVIDER: S-EPMC12559308 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature